
Boback Ziaeian MD PhD
Echocardiography, Non-Invasive Cardiology, Preventive Cardiology
Assistant Professor
Join to view full profile
100 UCLA Medical PlzSte 630Los Angeles, CA 90024
Phone+1 310-825-9011
Fax+1 310-825-2092
Dr. Ziaeian is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ronald Reagan UCLA Medical CenterPost-Doctoral Fellowship, 2013 - 2016
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 2012 - 2016
Yale-New Haven Medical CenterResidency, Internal Medicine, 2008 - 2011
University of California, Irvine, School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2011 - 2027
CT State Medical License 2011 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease- National Board of EchocardiographyDiplomate
Publications & Presentations
PubMed
- Dashboard-Directed Intervention to Improve Guideline-Directed Heart Failure Therapy for Veterans.Qicong Sheng, Nicholas K Brownell, Jeffrey J Hsu, Donald S Chang, Gregg C Fonarow
JACC. Advances. 2026-07-15 - Sisyphean Task of Cardiovascular Prevention: Real Gains, Unequal Progress.Boback Ziaeian, Gregg C Fonarow
Circulation. 2026-06-16 - Cost Offset With Quadruple Therapy for Heart Failure.Mohammad Keykhaei, Sina Rashedi, Stephen J Greene, Clyde Yancy, Boback Ziaeian
JAMA Cardiology. 2026-06-10
Journal Articles
- National Trends in Heart Failure Hospitalizations and Readmissions from 2010 to 2017Manyoo A Agarwal, Gregg C Fonarow, Boback Ziaeian, JAMA Cardiology
- Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy with Outcome for Patients with Heart FailureBoback Ziaeian, Clyde W Yancy, JAMA Cardiology
- Perceived Barriers to Sacubitril/Valsartan Use in Patients with Heart FailureKevin S Shah, Boback Ziaeian, Freny V Mody, Ali Nsair, Gregg C Fonarow, Journal of Cardiac Failure
Authored Content
- Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy with Outcome for Patients with Heart FailureMay 2020
- Perceived Barriers to Sacubitril/Valsartan Use in Patients with Heart FailureAugust 2018
Press Mentions
More Americans Hospitalized, Readmitted for Heart FailureFebruary 16th, 2021
Surgisphere Data Used in Two COVID Studies Called into QuestionJune 3rd, 2020
Arterial Thrombosis in Patients with CancerApril 7th, 2020
Other Languages
- Spanish, Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








